D017319Chemicals & DrugsPhysiologyD27.505.954.444.600D27.505.954.600.710550.997124Photosensitizing AgentsFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersontrue1Assistant ProfessorAssistant ProfessorTianhaoWangTianhao Wang350057Wang, TianhaoAssistant Professor28083883Qiu H, Kim MM, Penjweini R, Finlay JC, Busch TM, Wang T, Guo W, Cengel KA, Simone CB, Glatstein E, Zhu TCPhotochemistry and photobiologyA Comparison of Dose Metrics to Predict Local Tumor Control for Photofrin-mediated Photodynamic Therapy. Photochem Photobiol. 2017 07; 93(4):1115-1122.Photochem Photobiol2017-02-22T00:00:002017A Comparison of Dose Metrics to Predict Local Tumor Control for Photofrin-mediated Photodynamic Therapy.true1Associate ProfessorAssociate Professor0.1654820.03893285research area of0.6638360.1561815subject area forDermatologySurgeryWarrenPietteWarren W. Piette349491Piette, WarrenProfessorSashaShafikhaniSasha H. Shafikhani41.87386750000000-87.67102690000000349571Shafikhani, SashaAssociate ProfessorChristopherGoetzChristopher Goetz349622Goetz, ChristopherProfessor6Assistant Professor5Associate Professor4Professor29300266Lhuillier L, Ghetemme C, Boich? M, Yahia R, Houmad N, Zaidi M, Goetz C, Perone JMCorneaVisibility and Depth of the Stromal Demarcation Line After Corneal Collagen Cross-Linking Using Anterior Segment Optical Coherence Tomography: Comparison Between Isoosmolar and Hypoosmolar Riboflavin. Cornea. 2018 May; 37(5):567-573.Cornea2018-05-01T00:00:002018Visibility and Depth of the Stromal Demarcation Line After Corneal Collagen Cross-Linking Using Anterior Segment Optical Coherence Tomography: Comparison Between Isoosmolar and Hypoosmolar Riboflavin.Neurological SciencesRush University, Rush Medical CollegeSrinivasVourgantiSrinivas Vourganti349748Vourganti, SrinivasAssistant Professortrue1ProfessorProfessorInternal Medicine, Division of Hematology, Oncology and Cell Therapy28619755Railkar R, Krane LS, Li QQ, Sanford T, Siddiqui MR, Haines D, Vourganti S, Brancato SJ, Choyke PL, Kobayashi H, Agarwal PKMolecular cancer therapeuticsEpidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer. Mol Cancer Ther. 2017 10; 16(10):2201-2214.Mol Cancer Ther2017-06-15T00:00:002017Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer.35857290Kim EJ, Mangold AR, DeSimone JA, Wong HK, Seminario-Vidal L, Guitart J, Appel J, Geskin L, Lain E, Korman NJ, Zeitouni N, Nikbakht N, Dawes K, Akilov O, Carter J, Shinohara M, Kuzel TM, Piette W, Bhatia N, Musiek A, Pariser D, Kim YH, Elston D, Boh E, Duvic M, Huen A, Pacheco T, Zwerner JP, Lee ST, Girardi M, Querfeld C, Bohjanen K, Olsen E, Wood GS, Rumage A, Donini O, Haulenbeek A, Schaber CJ, Straube R, Pullion C, Rook AH, Poligone BJAMA dermatologyEfficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial. JAMA Dermatol. 2022 09 01; 158(9):1031-1039.JAMA Dermatol2022-09-01T00:00:002022Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial.29486459Soleimani H, Amini A, Taheri S, Sajadi E, Shafikhani S, Schuger LA, Reddy VB, Ghoreishi SK, Pouriran R, Chien S, Bayat MJournal of photochemistry and photobiology. B, BiologyThe effect of combined photobiomodulation and curcumin on skin wound healing in type I diabetes in rats. J Photochem Photobiol B. 2018 Apr; 181:23-30.J Photochem Photobiol B2018-02-21T00:00:002018The effect of combined photobiomodulation and curcumin on skin wound healing in type I diabetes in rats.true1ProfessorProfessortrue1Assistant ProfessorAssistant Professor